An Australian ophthalmology duo are streamlining keratoconus surgical procedures with their development of the CAIRS Plan tool, which they are making free to colleagues.
Read More
The role of the optometrist in keratoconus
At the completion of this article, the optometrist should be able to understand their role in management of patients with keratoconus, including:
Understand the crucial role optometrists play in identifying candidates for CXL
Understand how imaging modalities have improved a clinician’s diagnostic ability for early stages of keratoconus
Be able to provide patient education on CXL protocols and post-operative recovery.
Read More
Australian-made device by muPharma uses ultrasound to non-invasively deliver eye therapies
Melbourne biotech company muPharma, founded by ophthalmologist Dr Harry Unger and Mr Mark Unger, has developed an investigational device that uses ultrasound to deliver therapies non-invasively through ocular tissues, offering potential advantages over the standard of care for some retinal and corneal diseases.
Read More
Read More
NSW Organ and Transplant Donation Service launches corneal transplant survey
The NSW Organ and Transplant Donation Service (NSW OTDS – incorporating the Lions Eye Bank) is undertaking a short survey to better understand the current experiences of corneal practitioners in the tissue donation process.
Read More
Read More
Zeiss and Precise Bio to accelerate bio-fabricated corneal tissue program
Carl Zeiss Meditec has revealed a new partnership with Precise Bio to develop fabricated corneal tissue, leveraging a new 4D bio-fabrication platform that is set to address a major unmet need in ophthalmology.
Read More
Read More
World-first consortium to fight corneal blindness launches in Sydney
Two leading Australian corneal surgeons are part of a new world-first national consortium that will develop bioengineered eye tissue to treat corneal blindness.
Read More
Read More
A new school in corneal collagen cross-linking
Corneal collagen cross-linking revolutionised treatment for keratoconus patients when it was introduced in the late 1990s, but it was a one-size-fits-all approach. Two decades later, capabilities have taken a significant leap, reducing risks and improving patient outcomes.
Read More
Advances in treating corneal disease
Advances in corneal research and development are shifting the landscape, potentially making transplantation of donor corneas – and even corneal surgeons – obsolete in future. RHIANNON BOWMAN investigates the homegrown projects leading the way.
Read More
Read More